WaferGen Bio Story

WaferGen Bio systems Inc -- USA Stock  

USD 6.9  0.00  0.00%

Macroaxis does not monitor all media channels or aggregates social signals for WaferGen Bio. But even though we do not provide professional-grade financial sentiment analysis on WaferGen Bio systems, we do publish noise-free headlines that can be used to derive useful patterns or even a trading strategy for WaferGen Bio. See also Your Current Watchlist.
Acquisition by Davidson Scott Richard of 387500 shares of WaferGen Bio subject to Rule 16b-3
Filed transaction by Wafergen Biosystems Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

WaferGen Bio systems Inc insider trading alert for grant of common stock warrant (right to buy) by Davidson Scott Richard, the corporate stakeholder, on September 26, 2017. This event was filed by Wafergen Biosystems Inc with SEC on 2013-09-05. Statement of changes in beneficial ownership - SEC Form 4

Story Momentum

This story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.

Similar stores for WaferGen Bio

a day ago at www.macroaxis.com 
Purchase by Joel Kanter of 91937 shares of WaferGen Bio
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. General open market or private purchase of non-derivative or derivative security
few days ago at www.macroaxis.com 
Purchase by Shivji Alnoor of 833334 shares of WaferGen Bio
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. General open market or private purchase of non-derivative or derivative security
over two weeks ago at www.macroaxis.com 
Acquisition by Shivji Alnoor of 150000 shares of WaferGen Bio subject to Rule 16b-3
Macroaxis News
Filed transaction by Wafergen Biosystems Inc director. Grant, award or other acquisition pursuant to Rule 16b-3

Did you try this?

Run Companies Directory Now
   

Companies Directory

Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Hide  View All  Next  Launch Companies Directory

Debt to Equity

Debt to Equity Comparative Analysis
  Debt to Equity 
      WaferGen Bio Comparables 
WaferGen Bio is currently under evaluation in debt to equity category among related companies. Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.